Browsing by Author "Irazoqui, Pedro"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Design and validation of a low-cost photomodulator for in vivo photoactivation of a mGluR5 inhibitor
    (Springer, 2023-12-04) Ajieren, Hans; Fox, Andrew; Biggs, Ethan; Albors, Gabriel; Llebaria, Amadeu; Irazoqui, Pedro; Medicine, School of Medicine
    Purpose: Severe side effects prevent the utilization of otherwise promising drugs in treatments. These side effects arise when drugs affect untargeted tissues due to poor target specificity. In photopharmacology, light controls the timing and the location of drug delivery, improving treatment specificity and pharmacokinetic control. Photopharmaceuticals have not seen widespread adoption in part because researchers do not always have access to reliable and reproducible light delivery devices at prices which fit within the larger research budget. Method: In this work, we present a customizable photomodulator for use in both wearable and implantable devices. For experimental validation of the photomodulator, we photolyse JF-NP-26 in rats. Results: We successfully drive in vivo photopharmacology with a tethered photomodulator and demonstrate modifications which enable the photomodulator to operate wirelessly. Conclusion: By documenting our photomodulator development, we hope to introduce researchers to a simple solution which significantly lowers the engineering barriers to photopharmacology research. Graphical abstract: Researchers present a photomodulator, a device designed to facilitate in vivo photopharmacology. They demonstrate the in vivo capabilities of the photomodulator by photoreleasing raseglurant, an mGluR5 inhibitor, to treat pain in an acute rat model and follow this study by showing how to reconfigure the photomodulator to work wirelessly and interface with other biomedical devices. Supplementary information: The online version contains supplementary material available at 10.1007/s13534-023-00334-3.
  • Thumbnail Image
    Item
    A Flexible Platform for Biofeedback-driven Control and Personalization of Electrical Nerve Stimulation Therapy
    (IEEE, 2015) Ward, Matthew P.; Qing, Kurt Y.; Otto, Kevin J.; Worth, Robert M.; John, Simon W. M.; Irazoqui, Pedro; Department of Neurological Surgery, IU School of Medicine
    Electrical vagus nerve stimulation is a treatment alternative for many epileptic and depressed patients whose symptoms are not well managed with pharmaceutical therapy. However, the fixed stimulus, open loop dosing mechanism limits its efficacy and precludes major advances in the quality of therapy. A real-time, responsive form of vagus nerve stimulation is needed to control nerve activation according to therapeutic need. This personalized approach to therapy will improve efficacy and reduce the number and severity of side effects. We present autonomous neural control, a responsive, biofeedback-driven approach that uses the degree of measured nerve activation to control stimulus delivery. We demonstrate autonomous neural control in rats, showing that it rapidly learns how to most efficiently activate any desired proportion of vagal A, B, and/or C fibers over time. This system will maximize efficacy by minimizing patient response variability and by minimizing therapeutic failures resulting from longitudinal decreases in nerve activation with increasing durations of treatment. The value of autonomous neural control equally applies to other applications of electrical nerve stimulation.